Table 2.
Baseline values of serum CTX-I and urinary CTX-II
| Placebo | 0.6 mg sCT | 0.8 mg sCT | p-value | |
|---|---|---|---|---|
| Females | ||||
| sCTX-I (ng/ml) | 0.758 (0.536-1.073) |
0.669 (0.503-0.891) |
0.555 (0.378-0.817) |
0.09 |
| uCTX-II (ng/mmol) | 303 (161-570) |
410 (268-626) |
293 (192-449) |
0.21 |
| Males | ||||
| sCTX-I (ng/ml) | 0.539 (0.413-0.704) |
0.588 (0.353-0.981) |
0.504 (0.340-0.747) |
0.64 |
| uCTX-II (ng/mmol) | 278 (200-387) |
256 (159-411) |
263 (153-455) |
0.91 |
Values given are geometric mean (± 1SD range). The p-value column refers to the significance of the comparison of the three treatment groups.